Biocryst Pharmaceuticals (BCRX) Total Non-Current Liabilities (2013 - 2019)
Biocryst Pharmaceuticals (BCRX) reported Total Non-Current Liabilities of $128.2 million for Q3 2019, up 5.27% quarter-over-quarter from $121.8 million in Q2 2019.
Biocryst Pharmaceuticals (BCRX) Total Non-Current Liabilities (2013 - 2019) Analysis & Trends
Biocryst Pharmaceuticals has reported Total Non-Current Liabilities for 5 years, with the latest figure at $128.2 million in Q3 2019.
- For the quarter ending Q3 2019, Total Non-Current Liabilities changed N/A year-over-year to $128.2 million; the trailing twelve-month figure through Sep 2019 stood at $128.2 million (changed N/A YoY), and the FY2018 full-year result was $94.9 million, changed N/A from the prior year.
- Total Non-Current Liabilities for Q3 2019 stood at $128.2 million, up from $121.8 million in the prior quarter.
- The five-year high for Total Non-Current Liabilities was $128.2 million in Q3 2019, with the low at $67.9 million in Q2 2016.
- Historically, Total Non-Current Liabilities has averaged $102.4 million across 3 years, with a median of $105.4 million in 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 18.28 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 11.64 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 599.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 44.12 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 1.24 Bn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 6.26 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 2.44 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 1.81 Bn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 1.13 Bn |
| 10 | Biocryst Pharmaceuticals | 2.02 Bn | 1.78 Bn | 151.04 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2019 | 128.21 Mn |
| Jun 30, 2019 | 121.80 Mn |
| Mar 31, 2019 | 115.94 Mn |
| Dec 31, 2018 | 94.90 Mn |
| Sep 30, 2016 | 85.61 Mn |
| Jun 30, 2016 | 67.86 Mn |
| Jun 30, 2014 | 49.08 Mn |
| Dec 31, 2013 | 49.99 Mn |